Profile
International Journal of Radiology & Medical Imaging Volume 1 (2015), Article ID 1:IJRMI-104, 2 pages
https://doi.org/10.15344/2456-446X/2015/104
Editorial
Metamorphosis of Nuclear Medicine

Issa Loutfi

Departments of Nuclear Medicine, Kuwait University, P. O. Box 24923, Safat 13110, Kuwait
Dr. Issa Loutfi, Departments of Nuclear Medicine, Kuwait University, P. O. Box 24923, Safat 13110, Kuwait; E-mail: loutfi@hsc.edu.kw
26 August 2015; 22 September 2015; 24 September 2015
Loutfi I (2015) Metamorphosis of Nuclear Medicine. Int J Radiol Med Imag 1: 104. doi: https://doi.org/10.15344/2456-446X/2015/104

References

  1. Patton JA, Townsend DW, Hutton BF (2009) Hybrid imaging technology: from dreams and vision to clinical devices. Semin Nucl Med 39: 247-263. View
  2. DeNardo GL, DeNardo SJ (2012) Concepts, consequences, and implications of theranosis. Semin Nucl Med 42: 147-150. View
  3. Travin MI (2014) Cardiac radionuclide imaging to assess patients with heart failure. Semin Nucl Med 44: 294-313. View
  4. Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, et al. (1996) Positron emission tomography with 2-[18F] Fluoro-2-deoxy- D-glucose and 16alpha-[18F] fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res 2: 933-939. View
  5. Bleeker-Rovers CP, Corstens FH, Van Der Meer JW, Oyen WJ (2004) Fever of unknown origin: prospective comparison of diagnostic value of (18)F-FDG PET and (111)In-granulocyte scintigraphy. Eur J Nucl Med Mol Imaging 31: 1342-1343. View
  6. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, et al. (2008) Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med 49: 68-78. View